| POLR2E |
POLR2E: DNA-directed RNA polymerases I, II, and III subunit RPABC1 |
POLR2F |
POLR2F, POLRF: DNA-directed RNA polymerases I, II, and III subunit RPABC2 |
217.000 |
Evidence |
|
| POLR2E |
POLR2E: DNA-directed RNA polymerases I, II, and III subunit RPABC1 |
POLR2L |
POLR2L: DNA-directed RNA polymerases I, II, and III subunit RPABC5 |
217.000 |
Evidence |
|
| POLR2B |
POLR2B: DNA-directed RNA polymerase II subunit RPB2 |
POLR2H |
POLR2H: DNA-directed RNA polymerases I, II, and III subunit RPABC3 |
217.000 |
Evidence |
O
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
217.000 |
Evidence |
|
| TSHB |
TSHB: Thyrotropin subunit beta precursor |
FSHB |
FSHB: Follitropin subunit beta precursor |
217.000 |
Evidence |
|
| AMBP |
AMBP, HCP, ITIL: AMBP protein precursor [Contains: Alpha-1-microglobulin |
C6 |
C6: Complement component C6 precursor |
217.000 |
Evidence |
|
| CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
217.000 |
Evidence |
|
| HGFAC |
HGFAC: Hepatocyte growth factor activator precursor |
C6 |
C6: Complement component C6 precursor |
217.000 |
Evidence |
|
| C1R |
C1R: Complement C1r subcomponent precursor |
C1S |
C1S: Complement C1s subcomponent precursor |
217.000 |
Evidence |
O
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
216.000 |
Evidence |
|
| CRKL |
CRKL: Crk-like protein |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
216.000 |
Evidence |
|
| EFNA1 |
EFNA1, EPLG1, LERK1, TNFAIP4: Ephrin-A1 precursor |
CNTN2 |
CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor |
216.000 |
Evidence |
|
| EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
EIF2B2 |
EIF2B2, EIF2BB: Translation initiation factor eIF-2B subunit beta |
214.000 |
Evidence |
O
|
| RRM1 |
RRM1, RR1: Ribonucleoside-diphosphate reductase large subunit |
RRM2 |
RRM2, RR2: Ribonucleoside-diphosphate reductase subunit M2 |
213.000 |
Evidence |
O
|
| B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
IGHE |
IGHE: Ig epsilon chain C region |
212.000 |
Evidence |
|
| ZFP36 |
ZFP36, G0S24, RNF162A, TIS11A, TTP: Tristetraproline |
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
211.000 |
Evidence |
|
| SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
211.000 |
Evidence |
|
| PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
IQGAP1 |
IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 |
210.000 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
DUSP21 |
DUSP21, LMWDSP21: Dual specificity protein phosphatase 21 |
209.000 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
209.000 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
209.000 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
209.000 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
209.000 |
Evidence |
O
|
| EGF |
EGF: Pro-epidermal growth factor precursor |
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
209.000 |
Evidence |
O
|
| SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
C1S |
C1S: Complement C1s subcomponent precursor |
209.000 |
Evidence |
|
-